Bilateral Synchronous Simultaneous Stone Surgery
Launched by MARMARA UNIVERSITY · Jul 23, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new approach called Bilateral Synchronous Simultaneous Stone Surgery (BSSSS) for patients with kidney stones. This method allows doctors to treat kidney stones in both kidneys at the same time, which can help reduce the number of surgeries a patient needs and make the overall process quicker. The study aims to see how well this technique works when using two specific types of surgery: percutaneous nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS).
To participate in this trial, patients should be scheduled for surgery to remove kidney stones and have stones in both kidneys. There are no specific exclusions, so if you're facing surgery for bilateral kidney stones, you may be eligible. Participants will receive the new surgical treatment and will be monitored to evaluate how effective it is. This trial is currently recruiting patients, and it’s a great opportunity for those looking for a potentially less invasive way to treat their condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients scheduled for kidney stone surgery according to European Association Urology, Urolithiasis guidelines
- • patients with bilateral kidney stones
- Exclusion Criteria:
- • none
About Marmara University
Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Yiloren Tanidir, Ass. Prof.
Principal Investigator
Marmara University, School of Medicine, Department of Urology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials